Cypress Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$222K Hold
614
0.17% 79
2026
Q1
$216K Hold
614
0.16% 77
2025
Q4
$201K Buy
+614
New +$195K 0.15% 72

Other funds holding AMGN

Cypress Advisory Group's AMGN Position: Q2 2026 in Review

Cypress Advisory Group held its Amgen (AMGN) position steady in Q2 2026 at 614 shares worth $222K. The position accounts for 0.17% of the portfolio, ranked #79.

Cypress Advisory Group first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cypress Advisory Group held 614 shares of Amgen worth $222K as of Q2 2026.
  • Cypress Advisory Group left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.17% of Cypress Advisory Group's portfolio in Q2 2026, its #79 holding.
  • Cypress Advisory Group first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cypress Advisory Group's 13F filing for Q2 2026, filed 17 Jul 2026.